Back
Intellia Therapeutics, Inc. Stock Predictions
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Buy
65
NTLA
Intellia Therapeutics, Inc.
Last Price:
$15.52
Seasonality Move:
-5.17%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Intellia Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Intellia Therapeutics, Inc. has on average historically risen by 40.3% based on the past 9 years of stock performance.
-
Intellia Therapeutics, Inc. has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Intellia Therapeutics, Inc. Stock Undervalued?The current Intellia Therapeutics, Inc. [NTLA] share price is $15.90. The Score for NTLA is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
NTLA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Intellia Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Intellia Therapeutics, Inc. has on average historically risen by 40.3% based on the past 9 years of stock performance.
Intellia Therapeutics, Inc. Stock Rating
Buy
65
Intellia Therapeutics, Inc. (NTLA)
is a Buy
Is Intellia Therapeutics, Inc. overpriced?
-
Intellia Therapeutics, Inc. has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Intellia Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
intelliatx.com
52-Week Data
52-Week High:
28.25
52-Week Low:
5.90
Prediction Charts
Market Cap:
1.8B
Price in USD:
15.90
Volume:
10.5M
Beta:
2.09
Technical Analysis
SMA50:
9.73
SMA100:
13.48
SMA200:
11.55
52-Wk Change:
44.41%
Stock Predictions
-
Is Intellia Therapeutics, Inc. stock public?Yes, Intellia Therapeutics, Inc. is a publicly traded company.
-
What is the Intellia Therapeutics, Inc. stock quote today?The Intellia Therapeutics, Inc. stock price is 15.90 USD today.
-
How to buy Intellia Therapeutics, Inc. stock online?You can buy Intellia Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-31 | 9.06 | 8.99 | 9.14 | 8.94 |
| Jan-5 | 9.21 | 9.37 | 9.70 | 9.13 |
| Jan-6 | 9.37 | 9.73 | 10.17 | 9.31 |
| Jan-7 | 9.84 | 10.13 | 10.58 | 9.77 |
| Jan-8 | 10.72 | 10.52 | 10.74 | 10.32 |
| Jan-9 | 10.98 | 10.38 | 10.98 | 10.13 |
| Jan-12 | 10.41 | 11.43 | 11.45 | 10.15 |
| Jan-13 | 11.61 | 11.74 | 12.29 | 11.20 |
| Jan-14 | 11.75 | 12.02 | 12.34 | 11.66 |
| Jan-15 | 11.99 | 11.87 | 12.35 | 11.34 |
| Jan-16 | 11.88 | 12.50 | 12.75 | 11.70 |
| Jan-20 | 12.10 | 12.83 | 13.17 | 11.93 |
| Jan-21 | 12.98 | 14.03 | 14.49 | 12.94 |
| Jan-22 | 14.03 | 15.90 | 15.94 | 13.76 |
Intellia Therapeutics, Inc. Earnings
Intellia Therapeutics, Inc. Earnings Report: Per Share Intellia Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intellia Therapeutics, Inc. Forecast Revenue Growth
Intellia Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Intellia Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.04 per share.
* Intellia Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.